(4,4-difluoropiperidin-1-yl)-[1-[6-(2H-tetrazol-5-yl)-3-pyridinyl]pyrrolo[2,3-b]pyridin-5-yl]methanone
C19H16F2N8O — CID 156811043
Data last refreshed: (MolForge compound catalog, from PubChem)
About (4,4-difluoropiperidin-1-yl)-[1-[6-(2H-tetrazol-5-yl)-3-pyridinyl]pyrrolo[2,3-b]pyridin-5-yl]methanone
(4,4-difluoropiperidin-1-yl)-[1-[6-(2H-tetrazol-5-yl)-3-pyridinyl]pyrrolo[2,3-b]pyridin-5-yl]methanone (PubChem CID 156811043) has the molecular formula C19H16F2N8O and a molecular weight of 410.39 g/mol. Its IUPAC name is (4,4-difluoropiperidin-1-yl)-[1-[6-(2H-tetrazol-5-yl)-3-pyridinyl]pyrrolo[2,3-b]pyridin-5-yl]methanone.
Molecular Properties
| Compound Name | (4,4-difluoropiperidin-1-yl)-[1-[6-(2H-tetrazol-5-yl)-3-pyridinyl]pyrrolo[2,3-b]pyridin-5-yl]methanone |
|---|---|
| PubChem CID | 156811043 |
| Molecular Formula | C19H16F2N8O |
| Molecular Weight | 410.39 g/mol |
| Exact Mass | 410.14 |
| IUPAC Name | (4,4-difluoropiperidin-1-yl)-[1-[6-(2H-tetrazol-5-yl)-3-pyridinyl]pyrrolo[2,3-b]pyridin-5-yl]methanone |
| SMILES | O=C(c1cnc2c(ccn2-c2ccc(-c3nn[nH]n3)nc2)c1)N1CCC(F)(F)CC1 |
| InChI | InChI=1S/C19H16F2N8O/c20-19(21)4-7-28(8-5-19)18(30)13-9-12-3-6-29(17(12)23-10-13)14-1-2-15(22-11-14)16-24-26-27-25-16/h1-3,6,9-11H,4-5,7-8H2,(H,24,25,26,27) |
| InChIKey | QUIXLLXOKNNGLW-UHFFFAOYSA-N |
| XLogP | 2.47 |
| TPSA | 105.48 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 3 |
| Heavy Atoms | 30 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 410.39 |
| LogP ≤ 5 | 2.47 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 156811043 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.